Off-The-Shelf Adenoviral-Mediated Immunotherapy via Bicistronic Expression of Tumor Antigen and iMyD88/CD40 Adjuvant

Molecular Therapy - United States
doi 10.1038/mt.2012.48
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells as an “Off-The-Shelf Immunotherapy” for Improvement in Cancer Treatment

Frontiers in Immunology
AllergyImmunology
2017English

MicroRNA Silencing Improves the Tumor Specificity of Adenoviral Transgene Expression

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy

Advancements in Genetic Engineering
2015English

Melanoma Antigen A12 Regulates Cell Cycle via Tumor Suppressor P21 Expression

Oncotarget
Oncology
2017English

Tumor-Shed Antigen CA125 Blocks Complement-Mediated Killing via Suppression of C1q-Antibody Binding

European Journal of Immunology
AllergyImmunology
2018English

Impaired Tumor Antigen Processing by Immunoproteasome-Expressing CD40-activated B Cells and Dendritic Cells

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2011English

Adenoviral-Mediated Gene Transfer Restores Plasma ADAMTS13 Antigen and Activity in ADAMTS13 Knockout Mice

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2009English

Fucci2a:A Bicistronic Cell Cycle Reporter That Allows Cre Mediated Tissue Specific Expression in Mice

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2014English

Utilizing the Adjuvant Properties of CD1d-dependent NK T Cells in T Cell–mediated Immunotherapy

Journal of Clinical Investigation
Medicine
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy